Quick Answer
Clearside Biomedical, Inc. reported Research And Development Expense of $18.59 million for the year ending 2024.
- Clearside Biomedical, Inc. showed a decrease of -10.8% in Research And Development Expense from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2014 to 2024), Clearside Biomedical, Inc.'s Research And Development Expense has grown by 177.8%.
- Historical annual values: Fiscal year 2024: $18.59 million | Fiscal year 2023: $20.85 million | Fiscal year 2022: $19.63 million | Fiscal year 2021: $18.54 million | Fiscal year 2020: $15.07 million | Fiscal year 2019: $15.66 million | Fiscal year 2018: $68.29 million | Fiscal year 2017: $49.05 million | Fiscal year 2016: $19.46 million | Fiscal year 2015: $10.76 million | Fiscal year 2014: $6.69 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: